Home > Healthcare > Medical Devices > Diagnostic Devices > Sexual Health Testing Market

Sexual Health Testing Market Size

Report ID: GMI5799
Published Date: May 2023
Report Format: PDF

Download Free Sample

Sexual Health Testing Market Size

Sexual Health Testing Market size was valued at over USD 90 billion in 2022 and is projected to register over 5.3% CAGR between 2023 and 2032 owing to rising awareness regarding STDs and its diagnosis

To get key market trends

Download Free Sample

Sexual health testing refers to the process of diagnosing and screening for sexually transmitted infections (STIs) and other conditions related to sexual health. Testing is crucial for identifying infections, determining appropriate treatment, and preventing the spread of diseases. Additionally, the high prevalence of sexually transmitted diseases (STDs) is accelerating market growth. For instance, STDs have a substantial global impact, affecting millions of people each year. According to the World Health Organization (WHO), there are an estimated 376 million new cases of four common sexually transmitted infections including gonorrhoea, chlamydia, syphilis, and trichomoniasis, annually.

Sexual Health Testing Market Report Attributes
Report Attribute	Details
Base Year:	2022
Sexual Health Testing Market Size in 2022:	USD 90 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	5.3%
2032 Value Projection:	USD 152 Billion
Historical Data for:	2018 to 2022
No. of Pages:	200
Tables, Charts & Figures:	277
Segments covered:	Device type, Application, End-use, and Region
Growth Drivers:	Surge in prevalence of sexually transmitted diseases (STDs) Increasing government initiatives towards STDs Technological advancements in sexually transmitted disease diagnosis Rising awareness regarding STDs and its diagnosis
Pitfalls & Challenges:	Social taboo related to STDs Lack of reimbursement scenario

Learn more about the key segments shaping this market

Download Free Sample

Moreover, STD prevalence rate can vary significantly between regions and countries. Factors such as socioeconomic conditions, healthcare infrastructure, education, cultural norms, and sexual behaviours contribute to these variations. Additionally, stigma associated with STDs and sexual health, lack of awareness, and limited access to healthcare services can function as barriers to testing and prevention. Thus, regular microbiology testing, early diagnosis, and timely treatment are crucial for reducing the prevalence of STDs, thereby augmenting STD diagnostics market growth. In addition, several market players are emphasizing on research and development activities for the development of novel sexual health testing.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for sexual health testing was more than USD 90 billion in 2022 and will reach over USD 150 billion by 2032 propelled by the high prevalence of sexually transmitted diseases (STDs) across the world.

STD diagnostics market from Laboratory devices segment will surpass USD 100 billion by 2032 with an increase in device availability coupled with several businesses focusing on creating innovative technology.

Chlamydia application segment will reach over USD 36 billion by 2032 owing to the increased prevalence of chlamydia over the forecast years.

U.S. sexual health testing market will grow momentously to more than USD 55 billion by the 2032 on account of high spending on healthcare management and rising disposable income in the country.